FDA approves flu vaccine for coming season

August 14, 2012
FDA approves flu vaccine for coming season
Two of the three strains picked weren't in last year's shot, experts note.

(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

"The best way to prevent influenza is by getting vaccinated each year," Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research, said in a statement. "It is especially important to get vaccinated this year because two of the three used in this season's influenza vaccines differ from the strains included in last year's vaccines."

Experts from the FDA, the U.S. Centers for Disease Control and Prevention and the , along with other , study global flu infection patterns to try to predict which strains of the virus are most likely to make people ill in the coming . Sometimes there is a mismatch between the strains in the vaccine and the strains that wind up infecting most people each season, but officials noted that even then the vaccine can lessen the severity of illnesses.

Six vaccine makers are licensed to provide the in the United States, and the 2012-2013 vaccine will include the following strains: A/California/7/2009 (H1N1)-like virus; A/Victoria/361/2011 (H3N2)-like virus; and B/Wisconsin/1/2012-like virus. The H1N1 virus is the same as the one included in last year's vaccine, while the other two differ from the strains used in the 2011-2012 vaccine, according to an FDA news release.

Between 5 percent and 20 percent of the U.S. population develops influenza each year, resulting in more than 200,000 hospitalizations from related complications. Influenza seasons can vary widely, with annual influenza-related deaths ranging from a low of about 3,000 to a high of about 49,000 people in the United States, the news release stated. The CDC recommends that everyone 6 months of age and older receive an annual .

The companies producing the 2012-2013 flu vaccines and the brand names of the vaccines are:

  • Afluria, manufactured by CSL Ltd.
  • Fluarix, manufactured by GlaxoSmithKline Biologicals
  • FluLaval, manufactured by ID Biomedical Corp.
  • FluMist, manufactured by MedImmune Vaccines Inc.
  • Fluvirin, manufactured by Novartis Vaccines and Diagnostics Ltd.
  • Fluzone, Fluzone High-Dose and Fluzone Intradermal, manufactured by Sanofi Pasteur

Explore further: FDA approves first 4-in-1 flu vaccine

More information: To prepare for the coming flu season, go to the U.S. Centers for Disease Control and Prevention.

Related Stories

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Four works better than three: An enhanced flu vaccine does the trick

April 4, 2012
An intranasal vaccine that includes four weakened strains of influenza could do a better job in protecting children from the flu than current vaccines, Saint Louis University research shows.

Recommended for you

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

New study generates more accurate estimates of state opioid and heroin fatalities

August 7, 2017
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings. Further complicating the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Tangent2
not rated yet Aug 14, 2012
For anyone interested in reading up on what exactly doctors know/need to know about vaccines that they push, take a look here at this revealing article:

http://fathernatu...#pid4785

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.